A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives

gan Vos, Joël, Menko, Fred, Jansen, Anna M., van Asperen, Christi J., Stiggelbout, Anne M., Tibben, Aad
Cyhoeddwyd 2010

Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners' and breast surgeons' current practice and prefer...

gan Nippert, Irmgard, Julian-Reynier, Claire, Harris, Hilary, Evans, Gareth, van Asperen, Christi J., Tibben, Aad, Schmidtke, Jörg
Cyhoeddwyd 2013

Do Preferred Risk Formats Lead to Better Understanding? A Multicenter Controlled Trial on Communicating Familial Breast Cancer Risks Using Different Risk Formats

gan Henneman, Lidewij, van Asperen, Christi J, Oosterwijk, Jan C, Menko, Fred H, Claassen, Liesbeth, Timmermans, Daniëlle RM
Cyhoeddwyd yn Patient Prefer Adherence (2020)

Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling

gan Ockhuysen-Vermey, Caroline F, Henneman, Lidewij, van Asperen, Christi J, Oosterwijk, Jan C, Menko, Fred H, Timmermans, Daniëlle RM
Cyhoeddwyd 2008

General Practitioners and Breast Surgeons in France, Germany, Netherlands and the UK show variable breast cancer risk communication profiles

gan Julian-Reynier, Claire, Bouhnik, Anne-Deborah, Evans, D Gareth, Harris, Hilary, van Asperen, Christi J, Tibben, Aad, Schmidtke, Joerg, Nippert, Irmgard
Cyhoeddwyd yn BMC Cancer (2015)

How women with a family history of breast cancer and their general practitioners act on genetic advice in general practice: prospective longitudinal study

gan de Bock, Geertruida H, van Asperen, Christi J, de Vries, Josephine M, Hageman, George C H A, Springer, Machiel P, Kievit, Job
Cyhoeddwyd 2001

Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany

gan Gadzicki, Dorothea, Evans, D. Gareth, Harris, Hilary, Julian-Reynier, Claire, Nippert, Irmgard, Schmidtke, Jörg, Tibben, Aad, van Asperen, Christi J., Schlegelberger, Brigitte
Cyhoeddwyd 2011

The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trial

gan Henneman, Lidewij, Oosterwijk, Jan C, van Asperen, Christi J, Menko, Fred H, Ockhuysen-Vermey, Caroline F, Kostense, Piet J, Claassen, Liesbeth, Timmermans, Daniëlle RM
Cyhoeddwyd 2013

Correction: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2

gan Mesman, Romy L. S., Calléja, Fabienne M. G. R., de la Hoya, Miguel, Devilee, Peter, van Asperen, Christi J., Vrieling, Harry, Vreeswijk, Maaike P. G.
Cyhoeddwyd yn Genet Med (2020)

Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2

gan Mesman, Romy L. S., Calléja, Fabienne M. G. R., de la Hoya, Miguel, Devilee, Peter, van Asperen, Christi J., Vrieling, Harry, Vreeswijk, Maaike P. G.
Cyhoeddwyd yn Genet Med (2020)

The functional impact of variants of uncertain significance in BRCA2

gan Mesman, Romy L. S., Calléja, Fabienne M. G. R., Hendriks, Giel, Morolli, Bruno, Misovic, Branislav, Devilee, Peter, van Asperen, Christi J., Vrieling, Harry, Vreeswijk, Maaike P. G.
Cyhoeddwyd yn Genet Med (2018)

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families

gan Potjer, Thomas P., Bollen, Sander, Grimbergen, Anneliese J.E.M., van Doorn, Remco, Gruis, Nelleke A., van Asperen, Christi J., Hes, Frederik J., van der Stoep, Nienke
Cyhoeddwyd yn Int J Cancer (2019)

Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐BRCA1/2 sib trios affected with breast cancer

gan Hilbers, Florentine S., van ‘t Hof, Peter J., Meijers, Caro M., Mei, Hailiang, Michailidou, Kyriaki, Dennis, Joe, Hogervorst, Frans B. L., Nederlof, Petra M., van Asperen, Christi J., Devilee, Peter
Cyhoeddwyd yn Int J Cancer (2020)

Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling

gan Hilbers, Florentine S., Meijers, Caro M., Laros, Jeroen F. J., van Galen, Michiel, Hoogerbrugge, Nicoline, Vasen, Hans F. A., Nederlof, Petra M., Wijnen, Juul T., van Asperen, Christi J., Devilee, Peter
Cyhoeddwyd 2013

Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial

gan van der Spek, Nadia, Vos, Joël, van Uden-Kraan, Cornelia F, Breitbart, William, Cuijpers, Pim, Knipscheer-Kuipers, Kitty, Willemsen, Vincent, Tollenaar, Rob AEM, van Asperen, Christi J, Verdonck-de Leeuw, Irma M
Cyhoeddwyd 2014

Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial

gan van der Spek, Nadia, Vos, Joël, van Uden-Kraan, Cornelia F, Breitbart, William, Cuijpers, Pim, Knipscheer-Kuipers, Kitty, Willemsen, Vincent, Tollenaar, Rob AEM, van Asperen, Christi J, Leeuw, Irma M Verdonck-de
Cyhoeddwyd yn Psychooncology (2018)

Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies

gan Gonzalez-Neira, Anna, Rosa-Rosa, Juan Manuel, Osorio, Ana, Gonzalez, Emilio, Southey, Melissa, Sinilnikova, Olga, Lynch, Henry, Oldenburg, Rogier A, van Asperen, Christi J, Hoogerbrugge, Nicoline, Pita, Guillermo, Devilee, Peter, Goldgar, David, Benitez, Javier
Cyhoeddwyd 2007

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting

gan de Bock, Geertruida H, Jacobi, Catharina E, Seynaeve, Caroline, Krol-Warmerdam, Elly MM, Blom, Jannet, van Asperen, Christi J, Cornelisse, Cees J, Klijn, Jan GM, Devilee, Peter, Tollenaar, Rob AEM, Brekelmans, Cecile TM, van Houwelingen, Johannes C
Cyhoeddwyd 2008

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

gan Huijts, Petra EA, Vreeswijk, Maaike PG, Kroeze-Jansema, Karin HG, Jacobi, Catharina E, Seynaeve, Caroline, Krol-Warmerdam, Elly MM, Wijers-Koster, Pauline M, Blom, Jannet C, Pooley, Karen A, Klijn, Jan GM, Tollenaar, Rob AEM, Devilee, Peter, van Asperen, Christi J
Cyhoeddwyd 2007

Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10

gan Huijts, Petra EA, van Dongen, Minka, de Goeij, Moniek CM, van Moolenbroek, Adrian J, Blanken, Freek, Vreeswijk, Maaike PG, de Kruijf, Esther M, Mesker, Wilma E, van Zwet, Erik W, Tollenaar, Rob AEM, Smit, Vincent THBM, van Asperen, Christi J, Devilee, Peter
Cyhoeddwyd 2011